Worth reading
75Important
Scored from 3 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
1.8
Year-on-year change in net sales (%)Wording
Conditional
How definitive the wording is.Results for this period
Third quarter2024年4月1日〜2024年12月31日ConsolidatedJapanese GAAPNet Sales7,063¥ millionYear on year +1.8%
Operating profit-184¥ million
Ordinary income-116¥ million
Net income attributable to owners of the parent-77¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit.
Financial position at period-end
Total assets14,075¥ million
of which net assets 11,159 ¥ million
The shaded area represents net assets as a proportion of total assets. It is calculated from the two amounts reported by the company.
Segment revenueFine Chemicals Business ¥2,950 million (YoY +19.8%), Flame Retardants Business ¥3,063 million (YoY -10.6%), Health Support Business ¥1,050 million (YoY +0.2%)
Segment profitFine Chemicals Business ¥494 million (YoY +37.8%), Flame Retardants Business ¥78 million (YoY -73.9%), Health Support Business ¥41 million (YoY -12.0%)
Outlook and shareholder returns
Revision to Earnings Forecast修正あり。詳細は本日公表の別資料を参照
Factors Behind Changes in Business Performance
ファインケミカル事業は電子材料製品等の堅調な需要により増収増益。難燃剤事業は市場環境の悪化と需要減少により減収減益だが、円安とコストダウン活動が一部寄与。ヘルスサポート事業は一部製品の終売で販売数量が減少し、減益。
Disclosure regarding the going concern assumption
None.
Breakdown of extraordinary income (loss)Extraordinary income No / Extraordinary loss Loss on disposal of non-current assets ¥0 million
Depreciation and amortization¥359 million
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2024年4月1日〜2024年12月31日 |
| Net Sales | ¥7,063 million (YoY +1.8%) |
| Operating profit | ¥-184 million |
| Ordinary income | ¥-116 million |
| Profit attributable to owners of the parent | ¥-77 million |
| Total assets | ¥14,075 million |
| Net assets | ¥11,159 million |
| Revision to Earnings Forecast | 修正あり。詳細は本日公表の別資料を参照 |
| Segment revenue | Fine Chemicals Business ¥2,950 million (YoY +19.8%), Flame Retardants Business ¥3,063 million (YoY -10.6%), Health Support Business ¥1,050 million (YoY +0.2%) |
| Segment profit | Fine Chemicals Business ¥494 million (YoY +37.8%), Flame Retardants Business ¥78 million (YoY -73.9%), Health Support Business ¥41 million (YoY -12.0%) |
| Depreciation and amortization | ¥359 million |
| Breakdown of extraordinary income (loss) | Extraordinary income No / Extraordinary loss Loss on disposal of non-current assets ¥0 million |
| Disclosure regarding the going concern assumption | None. |
| Factors Behind Changes in Business Performance | ファインケミカル事業は電子材料製品等の堅調な需要により増収増益。難燃剤事業は市場環境の悪化と需要減少により減収減益だが、円安とコストダウン活動が一部寄与。ヘルスサポート事業は一部製品の終売で販売数量が減少し、減益。 |
Items this document does not state (21)
Net income per shareOperating MarginEquity ratioCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodFull-year earnings forecastAnnual Dividend ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment lossChange in accounting policyChanges in the scope of consolidationMaterial subsequent eventsAvailability of Supplementary Financial Results MaterialsAvailability of Financial Results BriefingIssued Shares at Period-EndTreasury Shares at Period-End
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.顧客との取引深耕に取り組んだ結果、ファインケミカル事業では電子材料製品などの需要が堅調でした。一方、難燃剤事業では市場環境の悪化と需要減少が続き、ヘルスサポート事業では一部製品の終売により販売数量が減少しました。海外向け難燃剤販売では円安が追い風となり、コストダウン活動の効果も下期から表れたとしています。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.